Lexaria Bioscience Files S-1 for Securities Offering

TL;DR

Lexaria Bioscience just filed an S-1, looks like they're raising cash.

AI Summary

Lexaria Bioscience Corp. filed an S-1 form on June 3, 2024, to register securities. The company, incorporated in Nevada, is in the pharmaceutical preparations sector and is based in Kelowna, British Columbia. This filing indicates a potential offering of new shares or other securities to raise capital.

Why It Matters

This S-1 filing signals Lexaria Bioscience's intent to raise capital through the sale of securities, which could impact its stock price and future operations.

Risk Assessment

Risk Level: medium — S-1 filings often precede stock offerings, which can dilute existing shareholders or indicate the company needs funds, carrying inherent risks.

Key Numbers

• 333-279909 — SEC File Number (Identifies this specific registration filing)
• 20240603 — Filing Date (Date the S-1 was officially submitted)

Key Players & Entities

• Lexaria Bioscience Corp. (company) — Registrant
• Christopher Bunka (person) — Chairman and Chief Executive Officer
• Gregory Sichenzia (person) — Legal Counsel
• Avital Perlman (person) — Legal Counsel
• Nevada (jurisdiction) — State of Incorporation
• 2000 (year) — Year of Incorporation

FAQ

Key Financial Figures

• $0.001 — 2 shares of our common stock, par value $0.001 per share, issuable upon the exercise o
• $13,855,902 — rice of the Warrant for an aggregate of $13,855,902. Our registration of the shares of com
• $3.89 — ed sales price for our common stock was $3.89 per share and the last reported sales p
• $1.49 — sales price for our listed warrants was $1.49 per listed warrant. Investment in our

Filing Documents

• lxrp_s1.htm (S-1) — 222KB
• lxrp_ex51.htm (EX-5.1) — 7KB
• lxrp_ex231.htm (EX-23.1) — 2KB
• lxrp_ex232.htm (EX-23.2) — 2KB
• lxrp_ex107.htm (EX-FILING FEES) — 27KB
• lxrp_s1img2.jpg (GRAPHIC) — 14KB
• lxrp_s1img1.jpg (GRAPHIC) — 14KB
• lxrp_ex51img8.jpg (GRAPHIC) — 1KB
• lxrp_ex51img6.jpg (GRAPHIC) — 7KB
• lxrp_ex51img3.jpg (GRAPHIC) — 1KB
• 0001640334-24-000898.txt ( ) — 313KB

RISK FACTORS

RISK FACTORS 8 SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS 9

USE OF PROCEEDS

USE OF PROCEEDS 9 SELLING STOCKHOLDER 9

DESCRIPTION OF SECURITIES BEING REGISTERED

DESCRIPTION OF SECURITIES BEING REGISTERED 11 PLAN OF DISTRIBUTION 12 LEGAL MATTERS 14 EXPERTS 14 WHERE YOU CAN FIND MORE INFORMATION 14 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 15 2 Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of the registration statement that we filed with the SEC pursuant to which the Selling Stockholder named herein may, from time to time, offer and sell or otherwise dispose of the shares of our common stock covered by this prospectus. As permitted by the rules and regulations of the SEC, the registration statement filed by us includes additional information not contained in this prospectus. This prospectus and the documents incorporated by reference into this prospectus include important information about us, the securities being offered and other information you should know before investing in our securities. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus is delivered or shares of common stock are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus, including the documents incorporated by reference therein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you under "Where You Can Find More Information" and "Incorporation of Certain Information by Reference" in this prospectus. You should rely only on this prospectus and the information incorporated or deemed to be incorporated by reference in this prospectus. We have not, and the Selling Stockholder has not, authorized anyone to give any information or to make any representation to you ot

Use of Proceeds

Use of Proceeds All shares of our common stock offered by this prospectus are being registered for the account of the Selling Stockholder and we will not receive any proceeds from the sale of these shares. However, we will receive proceeds from the exercise of the Warrant if the Warrant is exercised for cash. We intend to use those proceeds, if any, for working capital purposes.